Back to top
more

Saratoga Advantage Tr Health & Biotechnology Port Cl A: (MF: SHPAX)

(NASDAQ Mutual Funds) As of Feb 27, 2026 06:40 PM ET

$22.61 USD

+0.26 (1.16%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

5-Strong Sell of 5         5

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Jan 31, 2026

Total Return %* Percentile Rank Objective
YTD 1.60 8
3 months 8.46 21
6 months 21.37 62
1 Year 12.99 32
3 Year 6.59 68
5 Year 7.04 18
10 Year 6.58 95

* Annual for three years and beyond.

Zacks Premium Research for SHPAX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Strong Sell 5
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 36.42
% Yield NA
% SEC Yield NA
Net Assets (Mil $) 1/31/2026 4.95
% Turnover 1/31/2026 22.00

Risk

3 Year 5 Year 10 Year
Beta 0.61 0.64 0.70
Alpha -6.55 -3.00 -4.13
R Squared 0.30 0.44 0.53
Std. Dev. 12.97 14.52 14.39
Sharpe 0.20 0.32 4.00

Sector / Country Weightings

As of 1/31/2026 % of Portfolio
Health 51.05
Services 19.37
Retail Trade 16.46
Finance 5.59
Other 3.99
Technology 3.54

Portfolio Holdings

Top Equity Holdings
(As of 8/31/2025)
% of Portfolio Value (Mil$)
AMGEN INC 5.82 0.57
AMERISOURCEBERGEN CORP 5.66 0.56
MCKESSON CORP 5.62 0.55
CARDINAL HEALTH INC 5.18 0.51
NOVARTIS AG ADR 4.80 0.47
EXELIXIS INC 4.70 0.46
TOTAL*MONEY MARKET 4.42 0.44
UNITED THERAPEUTICS 4.33 0.43
JAZZ PHARMACEUTICALS PLC 4.20 0.41

Stock Holding % of Net Assets

As Of 8/31/2025
Total Issues 27
Avg. P/E 22.07
Avg. P/Book 3.91
Avg. EPS Growth 12.47
Avg. Market Value (Mil $) 105,304

Composition

% of Portfolio
Stocks 96.00
Foreign Stocks 11.95
Cash 4.42
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 0.00
Other -0.42
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth NA
Large Value NA
Small Growth NA
Small Value NA
Foreign Stock NA
Emerging Market NA
Precious Metal NA
Intermediate Bond NA
Foreign Bond NA
High Yield Bond NA